CFO Tobin Schilke sold $47K of Revance Therapeutics, Inc.

Sold$47,204

$5.04Price

9,361Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Mar 18. Filed Tue, Mar 19, 2:44 PM ET, during the session. Not investment advice.